The environmental risk factors prior to conception associated with placenta accreta spectrum: An umbrella review.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 10 02 2022
revised: 04 05 2022
accepted: 12 05 2022
pubmed: 19 5 2022
medline: 31 8 2022
entrez: 18 5 2022
Statut: ppublish

Résumé

The present umbrella review evaluated the environmental risk factors prior to conception associated with placenta accrete spectrum(PAS) based on meta-analyses and systematic reviews. We searched PubMed, Scopus, and Web of Science until October 14, 2021. All meta-analyses that had focused on assessing the risk factors associated with the PAS were included. We calculated summary effect estimates, 95% CI, heterogeneity I², 95% prediction interval, small-study effects, excess significance biases, and sensitive analysis. The quality of the meta-analyses was evaluated with A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2). The risk factor of in-vitro fertilization (IVF) (OR 5.03, 95% CI: 3.34, 7.56) was graded as suggestive evidence (class III). The multiple gestation (OR 1.90, 95% CI: 1.26, 2.88) was graded as the risk factor with weak evidence (class IV). Hypertension disorders (OR 0.5, 95% CI: 0.30, 0.82), low socioeconomic status (SES) (OR 0.51, 95% CI: 0.37, 0.71) (class IV) and male fetus (OR 0.79, 95% CI: 0.74, 0.84) (class III) were as the protective factors (class IV). The methodological quality of four of the included meta-analyses, based on AMSTAR 2, was low and three meta-analyses were critically low. The multifetal gestation and IVF were environmental risk factors for the PAS, while hypertension disorders, low SES, and male fetus were the protective factors.

Sections du résumé

BACKGROUND BACKGROUND
The present umbrella review evaluated the environmental risk factors prior to conception associated with placenta accrete spectrum(PAS) based on meta-analyses and systematic reviews.
MATERIALS AND METHODS METHODS
We searched PubMed, Scopus, and Web of Science until October 14, 2021. All meta-analyses that had focused on assessing the risk factors associated with the PAS were included. We calculated summary effect estimates, 95% CI, heterogeneity I², 95% prediction interval, small-study effects, excess significance biases, and sensitive analysis. The quality of the meta-analyses was evaluated with A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2).
RESULT RESULTS
The risk factor of in-vitro fertilization (IVF) (OR 5.03, 95% CI: 3.34, 7.56) was graded as suggestive evidence (class III). The multiple gestation (OR 1.90, 95% CI: 1.26, 2.88) was graded as the risk factor with weak evidence (class IV). Hypertension disorders (OR 0.5, 95% CI: 0.30, 0.82), low socioeconomic status (SES) (OR 0.51, 95% CI: 0.37, 0.71) (class IV) and male fetus (OR 0.79, 95% CI: 0.74, 0.84) (class III) were as the protective factors (class IV). The methodological quality of four of the included meta-analyses, based on AMSTAR 2, was low and three meta-analyses were critically low.
CONCLUSION CONCLUSIONS
The multifetal gestation and IVF were environmental risk factors for the PAS, while hypertension disorders, low SES, and male fetus were the protective factors.

Identifiants

pubmed: 35584759
pii: S2468-7847(22)00089-7
doi: 10.1016/j.jogoh.2022.102406
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102406

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

Ensiyeh Jenabi (E)

Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Zohreh Salimi (Z)

Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Amir Mohammad Salehi (AM)

Medical Student, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: amirchsalehi19171917@gmail.com.

Salman Khazaei (S)

Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH